Xenia Hotels & Resorts (XHR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Voting matters and shareholder proposals
ISS recommended a “FOR” vote on Say-on-Pay and aligned with all Board recommendations except Proposal 3, which concerns amending the 2015 Incentive Award Plan.
Board urges a “FOR” vote on Proposal 3, which seeks to increase shares available under the 2015 Plan by 2,250,000, about 2.10% of total outstanding shares and LTIP Units.
If Proposal 3 is not approved, equity awards may be exhausted, limiting incentive compensation to cash, which is less aligned with shareholder interests.
Executive compensation and say-on-pay
Compensation program links pay to long-term performance, with a majority of NEO compensation in equity, 75% of which is performance-based.
Company has received at least 97% support for Say-on-Pay proposals over the past three years and consistent “For” recommendations from leading proxy advisors.
Performance-based equity awards require at least a 6% annualized total shareholder return to vest.
All equity awards have multi-year vesting to ensure retention and performance alignment; robust stock ownership guidelines apply.
Board of directors and corporate governance
Board unanimously recommends approval of Proposal 3 and highlights responsible grant practices.
Latest events from Xenia Hotels & Resorts
- Double-digit earnings growth in 2025 with strong demand; 2026 outlook remains positive.XHR
Q4 202514 Mar 2026 - Net income up, EBITDAre down, and guidance trimmed as renovations and expense pressures persist.XHR
Q2 20242 Feb 2026 - Q3 loss and margin pressure offset by occupancy gains, strong group demand, and project completions.XHR
Q3 202415 Jan 2026 - 2025 guidance projects 3.5–6.5% RevPAR growth and $244–$264M Adjusted EBITDAre.XHR
Q4 202423 Dec 2025 - Annual meeting covers director elections, pay, equity plan, auditor, and strong governance.XHR
Proxy Filing2 Dec 2025 - Board recommends approval of all proposals, including director elections and plan amendment.XHR
Proxy Filing2 Dec 2025 - Q1 2025 net income and RevPAR surged, but guidance was trimmed amid macro uncertainty.XHR
Q1 202528 Nov 2025 - Q2 net income soared over 259% on asset sale and group demand, with raised full-year guidance.XHR
Q2 202516 Nov 2025 - Year-to-date net income and EBITDAre rose despite a Q3 net loss and flat RevPAR.XHR
Q3 20252 Nov 2025